All Relations between Neuromyelitis Optica and nmo

Publication Sentence Publish Date Extraction Date Species
Raja Sawaya, Wael Radwa. Sarcoidosis associated with neuromyelitis optica. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 20. issue 8. 2014-01-30. PMID:23683743. neuromyelitis optica (nmo) is an autoimmune disorder diagnosed by an elongated spinal cord lesion associated with unilateral or bilateral optic neuritis and anti-aquaporin 4 (aqp4) antibodies in the serum. 2014-01-30 2023-08-12 Not clear
Soo Il Choi, Yeon Ju Lee, Do Wan Kim, Jong Yeun Yan. A case of neuromyelitis optica misdiagnosed as cervicogenic headache. The Korean journal of pain. vol 27. issue 1. 2014-01-30. PMID:24478906. neuromyelitis optica (nmo) is an inflammatory demyelinating disease of the central nervous system associated with longitudinally extensive myelitis and optic neuritis. 2014-01-30 2023-08-12 Not clear
Sandra Vanotti, Evangelina Valeria Cores, Barbara Eizaguirre, Luciana Melamud, Raúl Rey, Andrés Vill. Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis. Arquivos de neuro-psiquiatria. vol 71. issue 6. 2014-01-23. PMID:23828523. the aim of the present research was to investigate cognitive pattern of patients with neuromyelitis optica (nmo) and to compare it with multiple sclerosis (ms) patients' performance. 2014-01-23 2023-08-12 Not clear
Saurabh Lalan, Majid Khan, Bruce Schlakman, Alan Penman, Joseph Gatlin, Robert Herndo. Differentiation of neuromyelitis optica from multiple sclerosis on spinal magnetic resonance imaging. International journal of MS care. vol 14. issue 4. 2014-01-23. PMID:24453753. in order to examine the accuracy of magnetic resonance imaging (mri)-based diagnosis of neuromyelitis optica (nmo) versus multiple sclerosis (ms), we performed a retrospective, rater-blinded review of 29 cases of nmo and 30 cases of ms using the criteria of long (more than three vertebral levels), continuous lesions with a central cord location for nmo and more peripheral and patchy lesions for ms. 2014-01-23 2023-08-12 Not clear
Ruth Ann Marrie, Caroline Gryb. The incidence and prevalence of neuromyelitis optica: a systematic review. International journal of MS care. vol 15. issue 3. 2014-01-23. PMID:24453773. interest in neuromyelitis optica (nmo) has increased substantially over the last few years, but it is not known whether nmo has the same geographic and temporal variations in disease risk as multiple sclerosis (ms). 2014-01-23 2023-08-12 Not clear
Honghao Wang, Kai Wang, Conghui Wang, Xiaonan Zhong, Wei Qiu, Xueqiang H. Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica. Multiple sclerosis (Houndmills, Basingstoke, England). vol 19. issue 7. 2014-01-21. PMID:23012252. multiple sclerosis (ms) and neuromyelitis optica (nmo) are immune-mediated inflammatory diseases of the central nervous system. 2014-01-21 2023-08-12 Not clear
Denis Bernardi Bichuetti, Enedina Maria Lobato de Oliveira, Nilton Amorin de Souza, Mar Tintoré, Alberto Alain Gabba. Patients with neuromyelitis optica have a more severe disease than patients with relapsingremitting multiple sclerosis, including higher risk of dying of a demyelinating disease. Arquivos de neuro-psiquiatria. vol 71. issue 5. 2014-01-17. PMID:23689404. although neuromyelitis optica (nmo) is known to be a more severe disease than relapsing-remitting multiple sclerosis (rrms), few studies comparing both conditions in a single center have been done. 2014-01-17 2023-08-12 Not clear
Ju-Hong Min, Patrick Waters, Angela Vincent, Eun-Suk Kang, Sujin Lee, Dong Kyoo Lee, Kwang Ho Lee, Byoung Joon Ki. Symptomatic brain involvement as the initial manifestation of neuromyelitis optica. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 20. issue 7. 2014-01-16. PMID:23673142. neuromyelitis optica (nmo) is an inflammatory demyelinating disorder that predominantly affects the optic nerve and spinal cord; however, symptomatic brain involvement is not rare and is sometimes an initial manifestation in nmo. 2014-01-16 2023-08-12 Not clear
Kazuo Fujihar. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. vol 102. issue 9. 2014-01-15. PMID:24228437. multiple sclerosis (ms) and neuromyelitis optica (nmo)]. 2014-01-15 2023-08-12 Not clear
Karolina Dembinski, Maria Gieron-Korthals, Carlos R Martinez, Lisa Rodrigue. Neuromyelitis optica in child: diagnostic and therapeutic challenges. Case reports in pediatrics. vol 2013. 2014-01-06. PMID:24392237. neuromyelitis optica (nmo) is a rare syndrome of severe inflammatory demyelination of the central nervous system, causing attacks of optic neuritis and transverse myelitis. 2014-01-06 2023-08-12 Not clear
Joanna Kitley, Maria Isabel Leite, Wilhelm Küker, Gerardine Quaghebeur, Jithin George, Patrick Waters, Mark Woodhall, Angela Vincent, Jacqueline Palac. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA neurology. vol 70. issue 11. 2013-12-30. PMID:23999580. aquaporin 4 antibody-negative neuromyelitis optica (nmo) is rare when good assays are used. 2013-12-30 2023-08-12 Not clear
Silje Agnethe Stokke Kvistad, Stig Wergeland, Øivind Torkildsen, Kjell-Morten Myhr, Christian A Vedele. [Neuromyelitis optica]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. vol 133. issue 19. 2013-12-27. PMID:24129537. neuromyelitis optica (nmo) is a rare autoimmune inflammatory disease of the central nervous system that is characterized mainly by recurrent optic neuritis and longitudinally extensive transverse myelitis. 2013-12-27 2023-08-12 Not clear
Takuya Matsushita, Takahisa Tateishi, Noriko Isobe, Tomomi Yonekawa, Ryo Yamasaki, Dai Matsuse, Hiroyuki Murai, Jun-Ichi Kir. Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis. PloS one. vol 8. issue 4. 2013-12-26. PMID:23637915. differences in cytokine/chemokine profiles among patients with neuromyelitis optica (nmo), relapsing remitting multiple sclerosis (rrms), and primary progressive ms (ppms), and the relationships of these profiles with clinical and neuroimaging features are unclear. 2013-12-26 2023-08-12 Not clear
M J Magraner, F Coret, B Casanov. The effect of intravenous immunoglobulin on neuromyelitis optica. Neurologia (Barcelona, Spain). vol 28. issue 2. 2013-12-17. PMID:22841880. evaluate safety and tolerance levels for intravenous immunoglobulins (ivig) as treatment for neuromyelitis optica (nmo). 2013-12-17 2023-08-12 Not clear
Luisa Klotz, Heinz Wiend. Monoclonal antibodies in neuroinflammatory diseases. Expert opinion on biological therapy. vol 13. issue 6. 2013-12-16. PMID:23521026. however, some of these approaches are currently investigated or translated for use in other, rare neuroinflammatory diseases, such as neuromyelitis optica (nmo), inflammatory neuropathies and (neuro)-muscular disorders. 2013-12-16 2023-08-12 Not clear
Hiroaki Yaguchi, Ken Sakushima, Ikuko Takahashi, Hiroaki Nishimura, Moemi Yashima-Yamada, Masakazu Nakamura, Kazufumi Tsuzaka, Yasunori Maruo, Toshiyuki Takahashi, Ichiro Yabe, Hidenao Sasak. Efficacy of intravenous cyclophosphamide therapy for neuromyelitis optica spectrum disorder. Internal medicine (Tokyo, Japan). vol 52. issue 9. 2013-12-16. PMID:23648715. neuromyelitis optica (nmo) is an inflammatory disease that affects the optic nerve and spinal cord. 2013-12-16 2023-08-12 Not clear
Lekha Pandit, Sharik Mustafa, Ramya Kunder, Rajesh Shetty, Zulkifly Misri, Shivanand Pai, Rakshith Shett. Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: Experience from the Mangalore demyelinating disease registry. Annals of Indian Academy of Neurology. vol 16. issue 4. 2013-12-16. PMID:24339582. in resource-poor settings, the management of neuromyelitis optica (nmo) and nmo spectrum (nmos) disorders is limited because of delayed diagnosis and financial constraints. 2013-12-16 2023-08-12 Not clear
Jean-Baptiste Chanson, Melissa Alame, Nicolas Collongues, Frédéric Blanc, Marie Fleury, Gabrielle Rudolf, Jérôme de Seze, Thierry Vincen. Evaluation of clinical interest of anti-aquaporin-4 autoantibody followup in neuromyelitis optica. Clinical & developmental immunology. vol 2013. 2013-12-10. PMID:23710199. neuromyelitis optica (nmo) is an autoimmune disease in which a specific biomarker named nmo-igg and directed against aquaporin-4 (aqp4) has been found. 2013-12-10 2023-08-12 Not clear
Tatsuro Misu, Romana Höftberger, Kazuo Fujihara, Isabella Wimmer, Yoshiki Takai, Shuhei Nishiyama, Ichiro Nakashima, Hidehiko Konno, Monika Bradl, Ferenc Garzuly, Yasuto Itoyama, Masashi Aoki, Hans Lassman. Presence of six different lesion types suggests diverse mechanisms of tissue injury in neuromyelitis optica. Acta neuropathologica. vol 125. issue 6. 2013-12-03. PMID:23579868. neuromyelitis optica (nmo) is an autoimmune disease targeting aquaporin 4 (aqp4), localized mainly at the astrocytic foot processes. 2013-12-03 2023-08-12 Not clear
Puay-Wah Phuan, Hua Zhang, Nithi Asavapanumas, Michael Leviten, Arnon Rosenthal, Lukmanee Tradtrantip, A S Verkma. C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta neuropathologica. vol 125. issue 6. 2013-12-03. PMID:23677375. neuromyelitis optica (nmo) is an autoimmune disorder with inflammatory demyelinating lesions in the central nervous system, particularly in the spinal cord and optic nerve. 2013-12-03 2023-08-12 mouse